Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

181. Efficacy and safety of prolonged use of macrolide antibiotics versus placebo for moderate to severe COPD patientsÿ

Efficacy and safety of prolonged use of macrolide antibiotics versus placebo for moderate to severe COPD patientsÿ Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

182. Heparin and derivatives in asthma and COPD: a meta-analysis

Heparin and derivatives in asthma and COPD: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2018 PROSPERO

183. Exercise and physical activity in patients with COPD: a systematic review with network meta-analysis

Exercise and physical activity in patients with COPD: a systematic review with network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

184. Factors influencing participation and adherence to pulmonary rehabilitation programs with resistance training by patients with chronic obstructive pulmonary disease (COPD): a systematic review and synthesis of qualitative studies

Factors influencing participation and adherence to pulmonary rehabilitation programs with resistance training by patients with chronic obstructive pulmonary disease (COPD): a systematic review and synthesis of qualitative studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record

2018 PROSPERO

185. Validation of asthma-COPD (chronic obstructive pulmonary disease) overlap diagnoses in electronic healthcare databases: a protocol for a systematic review

Validation of asthma-COPD (chronic obstructive pulmonary disease) overlap diagnoses in electronic healthcare databases: a protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

186. The needs of informal carers of patients with chronic obstructive pulmonary disease (COPD): a protocol for systematic review

The needs of informal carers of patients with chronic obstructive pulmonary disease (COPD): a protocol for systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

187. Preoperative exercise therapy may improve the surgical outcomes of patients with lung cancer and COPD through a mechanism of strengthening muscle capacity: a systematic review and meta-analysis

Preoperative exercise therapy may improve the surgical outcomes of patients with lung cancer and COPD through a mechanism of strengthening muscle capacity: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2018 PROSPERO

188. Pulmonary rehabilitation using minimal equipment for people with chronic obstructive pulmonary disease (COPD) [Cochrane protocol]

Pulmonary rehabilitation using minimal equipment for people with chronic obstructive pulmonary disease (COPD) [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

189. Long-term, high-intensity non-invasive ventilation (NIV) in patients with stable COPD with chronic hypercapnic respiratory failure

Long-term, high-intensity non-invasive ventilation (NIV) in patients with stable COPD with chronic hypercapnic respiratory failure Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

190. The effects of physical exercise on biomarkers of oxidative stress and systemic inflammation in subjects with COPD

The effects of physical exercise on biomarkers of oxidative stress and systemic inflammation in subjects with COPD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

191. The effects of elastic resistance training in patients with COPD: a systematic review and meta-analysis

The effects of elastic resistance training in patients with COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

192. Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol

Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

193. Health economic evaluation of physiotherapy in patients with COPD

Health economic evaluation of physiotherapy in patients with COPD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2018 PROSPERO

194. The effect of nutritional supplements during pulmonary rehabilitation for COPD patients

The effect of nutritional supplements during pulmonary rehabilitation for COPD patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

195. Comparison of continuous flow versus demandÿoxygen delivery systems in patients with Chronic Obstructive Pulmonary Disease (COPD): a systematic review and meta-analysis

Comparison of continuous flow versus demandÿoxygen delivery systems in patients with Chronic Obstructive Pulmonary Disease (COPD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2018 PROSPERO

196. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study (PubMed)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study Oxidative stress contributes to chronic obstructive pulmonary disease (COPD) exacerbations and antioxidants can decrease exacerbation rates, although we lack data about the effect of such drugs on exacerbation duration.The RESTORE (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine in COPD) study was a prospective randomised, double-blind, placebo-controlled study, enrolling patients aged (...) 40-80 years with Global Initiative for Chronic Obstructive Lung Disease stage II/III. Patients received erdosteine 300 mg twice daily or placebo added to usual COPD therapy for 12 months. The primary outcome was the number of acute exacerbations during the study.In the pre-specified intention-to-treat population of 445 patients (74% male; mean age 64.8 years, forced expiratory volume in 1 s 51.8% predicted) erdosteine reduced the exacerbation rate by 19.4% (0.91 versus 1.13 exacerbations·patient

Full Text available with Trip Pro

2018 EvidenceUpdates Controlled trial quality: predicted high

197. Antioxidants in COPD: systematic review and meta-analysis

Antioxidants in COPD: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2018 PROSPERO

198. COPD

COPD COPD - Symptoms, diagnosis and treatment | BMJ Best Practice   Search  COPD Last reviewed: February 2019 Last updated: November 2018 Summary Progressive disease state characterised by airflow limitation that is not fully reversible. Suspected in patients with a history of smoking, occupational and environmental risk factors, or a personal or family history of chronic lung disease. Presents with progressive shortness of breath, wheeze, cough, and sputum production, including haemoptysis (...) . Diagnostic tests include pulmonary function tests, chest x-ray, chest computed tomography scan, oximetry, and arterial blood gas analysis. Patients should be encouraged to stop smoking or occupational exposure and be vaccinated against viral influenza and Streptococcus pneumoniae . Treatment options include bronchodilators, inhaled corticosteroids, and systemic corticosteroids. Long-term oxygen therapy improves survival in severe COPD. Definition COPD is a preventable and treatable disease state

2018 BMJ Best Practice

199. Which behavior change techniques are most effective in changing healthcare utilisation for COPD patients enrolled in self-management programmes? A systematic review and meta-regression

Which behavior change techniques are most effective in changing healthcare utilisation for COPD patients enrolled in self-management programmes? A systematic review and meta-regression Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2018 PROSPERO

200. Risk factors and consequences of hospital readmission in COPD patients: a systematic review

Risk factors and consequences of hospital readmission in COPD patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO